Vasilis Stavrinides1, Francesco Giganti2,3, Mark Emberton2,4, Caroline M Moore2,4. 1. Division of Surgery and Interventional Science, University College London, Charles Bell House, 43-45 Foley Street, W1W 7TS, London, UK. v.stavrinides@ucl.ac.uk. 2. Division of Surgery and Interventional Science, University College London, Charles Bell House, 43-45 Foley Street, W1W 7TS, London, UK. 3. Department of Radiology, University College London Hospitals NHS Trust, 235 Euston Road, NW1 2BU, London, UK. 4. Department of Urology, University College London Hospitals NHS Trust, 235 Euston Road, NW1 2BU, London, UK.
Abstract
INTRODUCTION: Recent technological advancements and the introduction of modern anatomical and functional sequences have led to a growing role for multiparametric magnetic resonance imaging (mpMRI) in the detection, risk assessment and monitoring of early prostate cancer. This includes men who have been diagnosed with lower-risk prostate cancer and are looking at the option of active surveillance (AS). The purpose of this paper is to review the recent evidence supporting the use of mpMRI at different time points in AS, as well as to discuss some of its potential pitfalls. METHODS: A combination of electronic and manual searching methods were used to identify recent, important papers investigating the role of mpMRI in AS. RESULTS: The high negative predictive value of mpMRI can be exploited for the selection of AS candidates. In addition, mpMRI can be efficiently used to detect higher risk disease in patients already on surveillance. CONCLUSION: Although there is an ongoing debate regarding the precise nature of its optimal implementation, mpMRI is a promising risk stratification tool and should be considered for men on AS.
INTRODUCTION: Recent technological advancements and the introduction of modern anatomical and functional sequences have led to a growing role for multiparametric magnetic resonance imaging (mpMRI) in the detection, risk assessment and monitoring of early prostate cancer. This includes men who have been diagnosed with lower-risk prostate cancer and are looking at the option of active surveillance (AS). The purpose of this paper is to review the recent evidence supporting the use of mpMRI at different time points in AS, as well as to discuss some of its potential pitfalls. METHODS: A combination of electronic and manual searching methods were used to identify recent, important papers investigating the role of mpMRI in AS. RESULTS: The high negative predictive value of mpMRI can be exploited for the selection of AS candidates. In addition, mpMRI can be efficiently used to detect higher risk disease in patients already on surveillance. CONCLUSION: Although there is an ongoing debate regarding the precise nature of its optimal implementation, mpMRI is a promising risk stratification tool and should be considered for men on AS.
Authors: Narhari Timilshina; Antonio Finelli; George Tomlinson; Anna Gagliardi; Beate Sander; Shabbir M H Alibhai Journal: Can Urol Assoc J Date: 2022-04 Impact factor: 1.862
Authors: Analena Elisa Handke; Markus Graefen; Tim Ullrich; Andreas Wibmer; Boris Alexander Hadaschik; Francesco Giganti; Lars Schimmöller; Jan Philipp Radtke Journal: Urologe A Date: 2021-10-07 Impact factor: 0.639
Authors: Kevin Martell; Hans Chung; Gerard Morton; Danny Vesprini; Chia-Lin Tseng; Ewa Szumacher; Patrick Cheung; Will Chu; Stanley Liu; Andrew Loblaw Journal: Can Urol Assoc J Date: 2022-08 Impact factor: 2.052
Authors: Mun Su Chung; Nam Hoon Cho; Jinu Kim; Youngheun Jo; Byung Il Yoon; Seung Hwan Lee Journal: World J Mens Health Date: 2020-07-01 Impact factor: 5.400
Authors: Kerri R Beckmann; Chris H Bangma; Jozien Helleman; Anders Bjartell; Peter R Carroll; Todd Morgan; Daan Nieboer; Aida Santaolalla; Bruce J Trock; Riccardo Valdagni; Monique J Roobol Journal: Prostate Date: 2022-03-07 Impact factor: 4.012